Elke Niebergall-Roth

5PUBLICATIONS
27CO-AUTHORS
Medical infection agents (incl. prions)Regenerative medicine (incl. stem cells)Nanotoxicology, health and safetyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 18, 2025
Dimethyl sulfoxide in cryopreserved mesenchymal stromal cell therapy products: is there a safety risk to patients?

Elke Niebergall-Roth, Mark Andreas Kluth

|Jun 10, 2023
Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5

Elke Niebergall-Roth, Kathrin Dieter, Cristina Daniele

|Dec 06, 2021
Allogeneic ABCB5+ mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trial.

Andreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth

Pageof 1